| Proteus mirabilis (SOUTHCENTRAL Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| amoxicillin/clavulanate | 100% n=31 | ||||||
| ampicillin | 75.7% n=280 | 97.5% n=40 | |||||
| ampicillin/sulbactam | 78.6% n=280 | 95% n=40 | |||||
| cefazolin | 82.9% n=280 | 92.5% n=40 | |||||
| cefotetan | 100% n=55 | ||||||
| cefuroxime | 92.7% n=150 | ||||||
| cefotaxime | 100% n=86 | ||||||
| ceftazidime | 99.5% n=193 | 100% n=40 | |||||
| ceftriaxone | 99.1% n=225 | 100% n=40 | |||||
| cefepime | 100% n=280 | 97.5% n=40 | |||||
| ciprofloxacin | 64.6% n=280 | 47.5% n=40 | |||||
| levofloxacin | 71.1% n=280 | 47.5% n=40 | |||||
| gatifloxacin | 72.2% n=54 | ||||||
| TMP/SMX | 74.6% n=138 | 65% n=40 | |||||
| gentamicin | 86.4% n=280 | 92.5% n=40 | |||||
| tobramycin | 87.1% n=280 | 90% n=40 | |||||
| amikacin | 100% n=31 | ||||||
| aztreonam | 93.5% n=31 | ||||||
| imipenem | 93.9% n=280 | 100% n=40 | |||||
| piperacillin | 70.5% n=173 | ||||||
| pip/taz | 98.2% n=278 | 100% n=40 | |||||
| ticarcillin/clavulanate | 98.8% n=86 | ||||||
| Totals | 85.9% n=4051 | 86.5% n=520 | |||||
This data is accurate as of: 11/22/2016 11:54:08 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, cefotetan, cefotaxime, gatifloxacin, amikacin, aztreonam, ticarcillin/clavulanate, ampicillin, ampicillin/sulbactam, cefazolin, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, levofloxacin, TMP/SMX, gentamicin, tobramycin, imipenem, pip/taz.
